Silo Pharma, Inc. (SILO) Balance Sheet
SILO balance sheet, 2025
December 31, 2025 · U.S. dollars$7.6M assets = $1.3M liabilities + $6.3M equity
Both columns are drawn to the same scale: what SILO owns equals what it owes plus shareholders’ equity. Hover a block for its value.
SILO financial health
Descriptive bands, not a rating. Fiscal 2025.
SILO balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $1.3M2016 | $7.6M2025 | +21.7%/yr | |
| Total liabilities | $453,0982016 | $1.3M2025 | +12.4%/yr | |
| Shareholders’ equity | $846,5062016 | $6.3M2025 | +25.0%/yr | |
| Cash & short-term investments | $579,2092016 | $6.9M2025 | +31.6%/yr | |
| Total debt | $22,3442018 | $703,4882023 | +99.4%/yr | |
| Net cash (debt) | $542,6292018 | $7.0M2023 | +$6.4M | |
| Working capital | $611,6332016 | $6.7M2025 | +$6.1M | |
| Book value per share | $4.722021 | $11.282025 | +24.3%/yr | |
| Debt / equity | 0.052018 | 0.112023 | +0.06 | |
| Shares outstanding | 1.9M2021 | 559K2025 | −26.5%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
SILO assets
SILO liabilities and equity
SILO debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
SILO balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $6.9M | $7.1M | $7.7M | $11.4M | $10.3M | $1.1M | $121,146 | $564,973 | $294,591 | $579,209 |
| Cash & equivalents | $4.7M | $3.9M | $3.5M | $11.4M | $9.8M | $1.1M | $111,752 | $336,679 | $294,591 | $579,209 |
| Short-term investments | $2.1M | $3.2M | $4.1M | $3,118 | $419,995 | $200 | $9,394 | $228,294 | $1.3M | — |
| Receivables | $0 | $0 | $0 | $66,010 | $61,210 | $23,500 | $200,000 | $0 | $0 | $58,549 |
| Inventory | $0 | $0 | $0 | $0 | −$61,210 | $33,484 | $156,366 | $26,973 | $0 | $0 |
| Other current assets | $528,960 | $30,957 | $15,970 | $135,894 | $145,324 | $241,091 | $16,333 | $34,031 | $1.3M | $26,973 |
| Total current assets | $7.4M | $7.1M | $7.7M | $11.6M | $10.4M | $1.4M | $493,845 | $625,977 | $1.6M | $664,731 |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $217,375 | $241,215 | $0 | $0 | $0 | $0 | $0 | $29,440 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.3M | $634,873 |
| Other non-current assets | $0 | $59,145 | $64,983 | $70,821 | $87,869 | $0 | $0 | $200,000 | $0 | $0 |
| Total assets | $7.6M | $7.4M | $7.7M | $11.6M | $10.5M | $1.4M | $493,845 | $855,417 | $1.6M | $1.3M |
| Liabilities | ||||||||||
| Accounts payable | $578,081 | $1.6M | $703,488 | $364,216 | $417,937 | $127,069 | $54,862 | $25,631 | $38,343 | $53,098 |
| Short-term debt | — | — | $703,488 | $364,216 | $417,937 | $14,654 | $61,875 | $22,344 | — | — |
| Deferred revenue | $72,102 | $72,102 | $72,102 | $72,102 | $72,102 | −$141,723 | −$116,737 | −$25,631 | — | — |
| Total current liabilities | $650,183 | $1.7M | $775,590 | $436,318 | $490,039 | $141,723 | $116,737 | $47,975 | $38,343 | $53,098 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $4,246 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $649,476 | $721,578 | $793,679 | $865,782 | $937,884 | $0 | $400,000 | $400,000 | $400,000 | $400,000 |
| Total liabilities | $1.3M | $2.4M | $1.6M | $1.3M | $1.4M | $145,969 | $516,737 | $447,975 | $438,343 | $453,098 |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $1,332 | $449 | $316 | $316 | $9,864 | $8,514 | $2,361 | $2,342 | $5,009 | $5,009 |
| Retained earnings (deficit) | −$19.5M | −$15.3M | −$10.9M | −$7.2M | −$3.3M | −$5.8M | −$2.7M | −$1.6M | −$470,388 | −$400,000 |
| Accumulated other comprehensive income | $5,828 | $2,419 | −$6,227 | — | — | — | −$400,000 | −$400,000 | −$1.1M | −$566,360 |
| Total shareholders' equity | $6.3M | $5.0M | $6.2M | $10.3M | $9.1M | $1.3M | −$22,892 | $407,442 | $1.2M | $846,506 |
| Key figures | ||||||||||
| Total debt | — | — | $703,488 | $364,216 | $417,937 | $18,900 | $61,875 | $22,344 | — | — |
| Net cash (debt) | — | — | $7.0M | $11.0M | $9.8M | $1.1M | $59,271 | $542,629 | — | — |
| Working capital | $6.7M | $5.5M | $6.9M | $11.1M | $9.9M | $1.3M | $377,108 | $578,002 | $1.6M | $611,633 |
| Tangible book value | $6.1M | $4.8M | $6.2M | $10.3M | $9.1M | $1.3M | −$22,892 | $378,002 | $1.2M | $846,506 |
| Book value per share | $11.28 | — | $2.01 | $4.53 | $4.72 | — | — | — | — | — |
| Shares outstanding | 559K | — | 3.1M | 2.3M | 1.9M | — | — | — | — | — |
| Current ratio | 11.36 | 4.29 | 9.90 | 26.52 | 21.23 | 10.07 | 4.23 | 13.05 | 42.81 | 12.52 |
| Quick ratio | 10.55 | 4.28 | 9.88 | 26.21 | 21.06 | 8.13 | 2.75 | 11.78 | 7.68 | 12.01 |
| Debt / equity | — | — | 0.11 | 0.04 | 0.05 | 0.01 | — | 0.05 | — | — |
| Equity / assets | 82.9% | 67.9% | 79.7% | 88.8% | 86.4% | 89.8% | −4.6% | 47.6% | 73.3% | 65.1% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $5.4M | $6.3M | $6.9M | $5.9M | $6.3M | $5.5M | $7.1M | $8.0M | $7.6M | $6.7M | $7.7M | $8.8M |
| Cash & equivalents | $3.3M | $3.9M | $4.7M | $3.9M | $4.3M | $3.1M | $3.9M | $4.9M | $4.5M | $2.7M | $3.5M | $199,839 |
| Short-term investments | $2.2M | $2.4M | $2.1M | $2.0M | $1.9M | $2.3M | $3.2M | $3.2M | $3.1M | $4.1M | $4.1M | $8.6M |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $69,600 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $280,870 | $529,386 | $528,960 | $225,880 | $113,062 | $152,731 | $30,957 | $246,454 | $120,288 | $133,764 | $15,970 | $79,909 |
| Total current assets | $5.7M | $6.8M | $7.4M | $6.2M | $6.4M | $5.6M | $7.1M | $8.3M | $7.7M | $6.9M | $7.7M | $8.9M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $211,500 | $214,438 | $217,375 | $220,312 | $223,250 | $238,123 | $241,215 | $244,308 | $247,400 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $26,997 | $0 | $0 | $0 | $56,226 | $57,685 | $59,145 | $60,604 | $62,064 | $63,523 | $64,983 | $66,442 |
| Total assets | $6.0M | $7.0M | $7.6M | $6.4M | $6.7M | $5.9M | $7.4M | $8.6M | $8.0M | $6.9M | $7.7M | $9.0M |
| Liabilities | ||||||||||||
| Accounts payable | $362,181 | $632,743 | $578,081 | $636,237 | $977,795 | $1.1M | $1.6M | $972,730 | $1.3M | $801,570 | $703,488 | $606,669 |
| Short-term debt | — | — | — | — | — | — | — | — | — | — | — | $606,669 |
| Deferred revenue | — | $72,102 | $72,102 | $72,102 | $72,102 | $72,102 | $72,102 | $72,102 | $72,102 | $72,102 | $72,102 | $72,102 |
| Total current liabilities | $1.1M | $704,845 | $650,183 | $708,339 | $1.0M | $1.2M | $1.7M | $1.0M | $1.3M | $873,672 | $775,590 | $678,771 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $631,450 | $649,476 | $667,502 | $685,527 | $703,553 | $721,578 | $739,604 | $757,629 | $775,654 | $793,680 | $811,706 |
| Total liabilities | $1.1M | $1.3M | $1.3M | $1.4M | $1.7M | $1.9M | $2.4M | $1.8M | $2.1M | $1.6M | $1.6M | $1.5M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $113 | $1,627 | $1,332 | $1,046 | $865 | $449 | $449 | $449 | $408 | $316 | $316 | $311 |
| Retained earnings (deficit) | −$22.0M | −$21.1M | −$19.5M | −$18.6M | −$17.5M | −$16.3M | −$15.3M | −$13.5M | −$12.6M | −$11.7M | −$10.9M | −$9.8M |
| Accumulated other comprehensive income | $6,830 | $8,721 | $5,828 | $11,345 | $9,564 | $10,704 | $2,419 | $19,797 | $8,026 | $26,104 | −$6,227 | −$723 |
| Total shareholders' equity | $4.9M | $5.7M | $6.3M | $5.0M | $4.9M | $4.0M | $5.0M | $6.8M | $6.0M | $5.3M | $6.2M | $7.5M |
| Key figures | ||||||||||||
| Total debt | — | — | — | — | — | — | — | — | — | — | — | $606,669 |
| Net cash (debt) | — | — | — | — | — | — | — | — | — | — | — | $8.2M |
| Working capital | $4.6M | $6.1M | $6.7M | $5.5M | $5.3M | $4.4M | $5.5M | $7.2M | $6.4M | $6.0M | $6.9M | $8.2M |
| Tangible book value | $4.7M | $5.5M | $6.1M | $4.8M | $4.7M | $3.8M | $4.8M | $6.5M | $5.7M | $5.3M | $6.2M | $7.5M |
| Book value per share | $4.45 | $6.22 | $7.10 | $8.05 | $11.75 | — | — | — | — | — | — | $2.41 |
| Shares outstanding | 1.1M | 914K | 888K | 622K | 419K | — | — | — | — | — | — | 3.1M |
| Current ratio | 5.36 | 9.65 | 11.36 | 8.70 | 6.07 | 4.73 | 4.29 | 7.91 | 5.84 | 7.87 | 9.90 | 13.14 |
| Quick ratio | 5.10 | 8.90 | 10.55 | 8.38 | 5.96 | 4.60 | 4.28 | 7.67 | 5.75 | 7.72 | 9.88 | 13.02 |
| Debt / equity | — | — | — | — | — | — | — | — | — | — | — | 0.08 |
| Equity / assets | 82.1% | 81.0% | 82.9% | 78.5% | 73.9% | 68.0% | 67.9% | 79.2% | 74.1% | 76.2% | 79.7% | 83.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 27, 2026); data from EODHD.
SILO financial position
At the end of fiscal 2025 (December 31, 2025), Silo Pharma had total assets of $7.6 million (up 2.6% from a year earlier), total liabilities of $1.3 million and shareholders' equity of $6.3 million. Its current ratio was 11.36. In the latest quarter (ended June 30, 2026) total assets were $6.0 million and equity $4.9 million.
Related: SILO income statement, SILO cash flow statement, SILO key metrics. See the SILO stock overview for the latest quote and news.
SILO balance sheet FAQ
What are Silo Pharma's total assets?
Silo Pharma reported total assets of $7.6 million at the end of fiscal 2025 (December 31, 2025), compared with $7.4 million a year earlier.
How much cash does Silo Pharma have?
Silo Pharma held $6.9 million in cash and short-term investments at the end of fiscal 2025.
What is Silo Pharma's book value?
Silo Pharma's shareholders' equity (book value) was $6.3 million at the end of fiscal 2025, or $11.28 per share.
What is Silo Pharma's current ratio?
Silo Pharma had current assets of $7.4 million and current liabilities of $0.7 million, a current ratio of 11.36 (it can cover its short-term obligations).
How much goodwill does Silo Pharma have?
Silo Pharma carried $0.2 million of goodwill and intangible assets, 2.9% of total assets, at the end of fiscal 2025.